1. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression
   Monica E. Reyes et al, 2017, Breast Cancer Research and Treatment CrossRef
2. Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials
   Junjie Lu et al, 2023, Frontiers in Oncology CrossRef